Identification
Transfer a portion of powdered Tablets, equivalent to about 20 mg of timolol maleate, to a suitable centrifuge tube containing about 5 mL of methanol. Agitate for 20 minutes, and centrifuge. Separately dissolve suitable quantities of
USP Timolol Maleate RS and
USP Hydrochlorothiazide RS in methanol to obtain Standard solutions each having a concentration of 10 mg per mL. Separately apply 3 µL of the test solution and of each Standard solution to a thin-layer chromatographic plate (see
Chromatography 621) coated with a 0.25-mm layer of chromatographic silica gel mixture. Develop the chromatogram using a solvent system consisting of a mixture of chloroform, methanol, and ammonium hydroxide (80:20:1) until the solvent front has moved about three-fourths of the length of the plate. Air-dry, and examine under short-wavelength UV light: the
RF values of the principal spots obtained from the Standard solutions correspond to those obtained from the test solution.
Dissolution 711
Medium:
0.1 N hydrochloric acid; 900 mL.
Apparatus 2:
50 rpm.
Time:
20 minutes.
Procedure
Determine the amount of timolol maleate (C
13H
24N
4O
3S·C
4H
4O
4) dissolved, employing the following procedure: Prepare a Standard solution of
USP Timolol Maleate RS in 0.1 N hydrochloric acid having a known concentration of about 11 µg per mL. Filter a portion of the solution under test, and transfer 10.0 mL of the clear filtrate to a suitable separator. Transfer 10.0 mL each of the Standard solution and 0.1 N hydrochloric acid, to provide the blank, to individual separators, and treat each of three separators as follows: Add 20.0 mL of ethyl acetate, mix for 1 minute, allow the phases to separate, and filter the aqueous layer into a suitable vessel, retaining the ethyl acetate layer from the solution under test for the hydrochlorothiazide determination. Determine the amount of C
13H
24N
4O
3S·C
4H
4O
4 dissolved from UV absorbances of the aqueous layer from the solution under test at the wavelength of maximum absorbance at about 293 nm in comparison with the aqueous layer from the Standard solution.
Determine the amount of hydrochlorothiazide (C
7H
8ClN
3O
4S
2) dissolved, employing the following procedure: Filter the ethyl acetate layer obtained previously from the solution under test through filter paper. Determine the amount of C
7H
8ClN
3O
4S
2 dissolved from UV absorbances at the wavelength of maximum absorbance at about 270 nm of the ethyl acetate layer from the solution under test in comparison with a Standard solution in ethyl acetate having a known concentration of
USP Hydrochlorothiazide RS.
Tolerances
Not less than 80% (Q) of each of the labeled amounts of C13H24N4O3S·C4H4O4 and C7H8ClN3O4S2, respectively, is dissolved in 20 minutes.
Related compounds
pH 3.0 Buffer and Mobile phase
Proceed as directed under Assay.
Standard solution
Dissolve an accurately weighed quantity of
USP Benzothiadiazine Related Compound A RS in methanol to obtain a solution having a known concentration of about 0.5 mg per mL. Transfer an accurately measured volume of this solution, and dilute quantitatively, and stepwise if necessary, with
Mobile phase to obtain a solution having a known concentration of about 0.5 µg per mL.
Test solution
Use the Assay preparation prepared as directed in the Assay.
Chromatographic system
Proceed as directed under Assay, except to chromatograph the Standard solution: the relative standard deviation for replicate injections is not more than 5.0%.
Procedure
Separately inject equal volumes (about 50 µL) of the
Standard solution and the
Test solution into the chromatograph, record the chromatograms, and measure the peak areas. Calculate the percentage of benzothiadiazine related compound A in the portion of Tablets taken by the formula:
100(C/L)(rU / rS),
in which
C is the concentration in µg per mL, of
USP Benzothiadiazine Related Compound A RS in the
Standard solution; L is the amount, in mg, of hydrochlorothiazide in the portion of Tablets taken, based on the labeled amount; and
rU and
rS are the peak areas of benzothiadiazine related compound A obtained from the
Test solution and
Standard solution, respectively: not more than 1.0% is found.
Assay
pH 3.0 phosphate buffer
Dissolve 13.6 g of monobasic potassium phosphate in 100 mL of water, adjust with phosphoric acid to a pH of 3.0 ± 0.05, and filter.
Mobile phase
Prepare a suitable filtered and degassed mixture of water, acetonitrile, methanol, and
pH 3.0 phosphate buffer (38:8:2:2), making adjustments if necessary (see
System Suitability under
Chromatography 621).
Standard preparation
Transfer about 50 mg of
USP Timolol Maleate RS, accurately weighed, to a 500-mL volumetric flask. Add 50
J mg of
USP Hydrochlorothiazide RS, accurately weighed,
J being the ratio of the labeled amount, in mg, of hydrochlorothiazide to the labeled amount, in mg, of timolol maleate per Tablet. Add 50 mL of 0.05 M monobasic sodium phosphate, and 125 mL of acetonitrile, sonicate for 4 minutes, dilute with water to volume, and mix. Pipet 5 mL into a 25-mL volumetric flask, dilute with acetonitrile solution (1 in 10) to volume, and mix.
Assay preparation
Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 20 mg of timolol maleate, to a 1-liter volumetric flask, add about 100 mL of 0.05 M monobasic sodium phosphate, 125 mL of acetonitrile, and 100 mL of water, and mix by mechanical means. Allow to stand for 16 hours, dilute with water to volume, mix, and filter.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 295-nm detector and a 4-mm × 30-cm column that contains packing L1. The flow rate is about 1.5 mL per minute. Chromatograph replicate injections of the
Standard preparation, and record the peak responses as directed for
Procedure: the relative standard deviation is not more than 1.5%; and the resolution,
R, between hydrochlorothiazide and timolol maleate is not less than 4.0.
Procedure
Separately inject equal volumes (about 50 µL) of the
Standard preparation and the
Assay preparation into the chromatograph by means of a suitable microsyringe or sampling valve, record the chromatograms, and measure the responses for the major peaks. The relative retention times are about 0.5 for benzothiadiazine related compound A, 0.6 for hydrochlorothiazide, and 1.0 for timolol maleate. Calculate the quantity, in mg, of hydrochlorothiazide (C
7H
8ClN
3O
4S
2) in the portion of Tablets taken by the formula:
1000C(rU / rS),
in which
C is the concentration, in mg per mL, of
USP Hydrochlorothiazide RS in the
Standard preparation; and
rU and
rS are the responses of the hydrochlorothiazide peak obtained from the
Assay preparation and the
Standard preparation, respectively. Calculate the quantity, in mg, of timolol maleate (C
17H
28N
4O
7S) by the same formula, changing the terms to refer to timolol maleate.